Fowler, N. H., Dickinson, M., Dreyling, M., Martinez-Lopez, J., Kolstad, A., Butler, J., . . . Thieblemont, C. (2022). Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: The phase 2 ELARA trial. Nature Medicine, 28(2), 325-332. https://doi.org/10.1038/s41591-021-01622-0
Citace podle Chicago (17th ed.)Fowler, Nathan Hale, et al. "Tisagenlecleucel in Adult Relapsed or Refractory Follicular Lymphoma: The Phase 2 ELARA Trial." Nature Medicine 28, no. 2 (2022): 325-332. https://doi.org/10.1038/s41591-021-01622-0.
Citace podle MLA (9th ed.)Fowler, Nathan Hale, et al. "Tisagenlecleucel in Adult Relapsed or Refractory Follicular Lymphoma: The Phase 2 ELARA Trial." Nature Medicine, vol. 28, no. 2, 2022, pp. 325-332, https://doi.org/10.1038/s41591-021-01622-0.